Man Group
ZYME icon

Man Group’s Zymeworks ZYME Stock Holding History

Man Group’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.75M Buy
189,890
+114,572
+152% +$2.71M 0.01% 1194
2025
Q4 		$1.98M Sell
75,318
-83,298
-53% -$1.82M ﹤0.01% 1453
2025
Q3 		$2.71M Buy
158,616
+123,210
+348% +$1.76M ﹤0.01% 1297
2025
Q2 		$444K Buy
35,406
+24,547
+226% +$292K ﹤0.01% 1870
2025
Q1 		$129K Buy
+10,859
New +$148K ﹤0.01% 2094
2024
Q2 		– Sell
-39,583
Closed -$416K – 2314
2024
Q1 		$416K Sell
39,583
-3,186
-7% -$35.4K ﹤0.01% 1846
2023
Q4 		$444K Buy
+42,769
New +$341K ﹤0.01% 1716
2023
Q3 		– Sell
-22,514
Closed -$166K – 1788
2023
Q2 		$195K Buy
+22,514
New +$202K ﹤0.01% 1824
2023
Q1 		– Sell
-18,289
Closed -$159K – 1953
2022
Q4 		$144K Sell
18,289
-142,256
-89% -$1,000K ﹤0.01% 1836
2022
Q3 		$987K Buy
+160,545
New +$968K ﹤0.01% 1292
2022
Q2 		– Sell
-64,400
Closed -$389K – 1578
2022
Q1 		$422K Buy
+64,400
New +$574K ﹤0.01% 1641
2020
Q3 		– Sell
-11,837
Closed -$427K – 1898
2020
Q2 		$427K Buy
+11,837
New +$436K ﹤0.01% 1489
2020
Q1 		– Sell
-44,294
Closed -$2.01M – 1933
2019
Q4 		$2.01M Buy
+44,294
New +$1.61M 0.01% 1329

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Man Group's ZYME Position: Q1 2026 in Review

Man Group increased its Zymeworks (ZYME) stake by 152% in Q1 2026, buying an estimated $2.71M and bringing the position to 189,890 shares worth $4.75M. The position accounts for 0.01% of the portfolio, ranked #1194.

Man Group first reported a position in ZYME in Q4 2019 and has held it in 13 quarters since. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Man Group held 189,890 shares of Zymeworks worth $4.75M as of Q1 2026.
  • Man Group bought 114,572 Zymeworks shares in Q1 2026, an estimated $2.71M.
  • Zymeworks made up 0.01% of Man Group's portfolio in Q1 2026, its #1194 holding.
  • Man Group first reported a position in Zymeworks in Q4 2019 and has held it in 13 quarters since.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.